Critical reappraisal of remdesivir investigational trials in COVID-19

被引:2
|
作者
Brouqui, P. [1 ]
Giraud-Gatineau, A. [1 ]
Raoult, D. [1 ]
机构
[1] Aix Marseille Univ, IRD, MEPHI, IHU Mediterranee Infect, Marseille, France
关键词
Clinical trials; COVID-19; remdesivir; treatment; CORONAVIRUS;
D O I
10.1016/j.nmni.2020.100745
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
During disease outbreaks, the pharmaceutical industry generally puts a lot of effort into promoting clinical trials studying their new drugs. We review evidence of the ten most recent reports on remdesivir. We conclude that it is far too premature to identify remdesivir as a curative or life-saving intervention during the COVID-19 pandemic. (C) 2020 The Author(s). Published by Elsevier Ltd.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Remdesivir and COVID-19
    Francesco Ferrara
    Raffaele La Porta
    Vilma D’Aiuto
    Antonio Vitiello
    Irish Journal of Medical Science (1971 -), 2021, 190 : 1237 - 1238
  • [2] Remdesivir and COVID-19
    Wang, Lei-Yun
    Cui, Jia-Jia
    Ouyang, Qian-Ying
    Zhan, Yan
    Guo, Cheng-Xian
    Yin, Ji-Ye
    LANCET, 2020, 396 (10256): : 953 - 954
  • [3] Remdesivir in covid-19
    Ferner, Robin E.
    Aronson, Jeffrey K.
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
  • [4] Remdesivir and COVID-19
    Ferrara, Francesco
    La Porta, Raffaele
    D'Aiuto, Vilma
    Vitiello, Antonio
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (03) : 1237 - 1238
  • [6] Remdesivir for patients with COVID-19
    Wu, Peter E.
    Morris, Andrew M.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (04) : E125 - E125
  • [8] Remdesivir (Veklury) for COVID-19
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1612): : 186 - 188
  • [9] Remdesivir bei COVID-19
    Redaktion Facharztmagazine
    MMW - Fortschritte der Medizin, 2022, 164 (2) : 65 - 65
  • [10] Remdesivir: A Review in COVID-19
    Blair, Hannah A.
    DRUGS, 2023, 83 (13) : 1215 - 1237